Hiv Vaccine
latest news & developments
The six-monthly anti-HIV jab could end Aids in SA by 2032
A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s while
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar
In December, the Global Fund and the US President’s Emergency Plan for Aids Relief committed to funding the roll-out of lenacapavir in countries they support
Glenda Gray steps down from South African Medical Research Council
Gray is the first female president and chief executive of the council and served as the chairperson of the research committee on Covid-19
Finding an HIV vaccine: Five lessons from the search for a Covid-19 jab
The Covid-19 pandemic has shown that vaccine development and testing timelines can be shrunk from decades to months, but not without shortcomings
Should everyone be getting the HIV prevention pill as part of this new study?
Only some study participants have access to the tablet that can cut the risk of HIV infection by more than 90%.
What’s next for South Africa’s experimental HIV vaccine
If it works, the world’s latest HIV vaccine candidate may make it to market quicker than we think – and become a routine childhood vaccination
Why I signed up for an HIV vaccine trial
Jane Mahlangu is set to become one of the first 100 people in South Africa to receive an experimental jab that could prevent HIV – and make history
South Africa on the cusp of HIV vaccine breakthrough
Recently the first participants in the HVTN 702 study received jabs of a vaccine that could stop HIV in its tracks
Could we mass-produce HIV immunity?
One tiny protein may hold the secret to ending the HIV pandemic.
Unique South African children may chart new path for HIV vaccines
A study conducted among almost 200 South African children is the largest of its kind.
#AIDS2016: From medical circumcision to vaccines, these seven things will change HIV
We know more than ever about how to prevent HIV infection, including what may someday lead to the world’s first HIV vaccine.
#AIDS2016 signals the beginning of research into a new generation of HIV vaccines
The time for an HIV vaccine is now
HIV vaccine – closer than ever
We are not there yet, but experts are optimistic about a jab to prevent HIV coming to market in the near future.
Comment: HIV researchers, citizens must be part of decisions
If the progress we see today is anything to go by, it means we are closer than ever to having an HIV vaccine.
In search of an HIV vaccine
Three SARChI Research Chairs are focusing on the holy grail of HIV vaccine development to develop a therapeutic vaccine against the virus.